Delivery Order SPE2DB24D2205-SPE2DB25FECRX

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 16, 2025. The contract has a firm fixed price of $2,004.75 and a completion date of January 17, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price of $7,360.76 and has an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $4,533.27 and a performance period through April 11, 2024. No set-aside designation was used for this...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The $1,295.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies. The contract has an ultimate completion date of October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of IMOVAX Rabies vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,339.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of December 10, 2024. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,227.50. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. The place of performance is Conshohocken, PA. This award is...
This federal contract award is for the procurement of IMOVAX RABIES VACCINE VIALS by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,421.14 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the supply of IMOVAX rabies vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,158.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 28, 2024. The contract is a delivery order with a firm fixed price and a completion date of July 1, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor and there is no...
This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), with a total ceiling value of $7,015.94. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,113.75 firm fixed-price delivery order is for IMOVAX RABIES VACCINE VIALS, with a performance period ending on May 29, 2025. The contract is not set aside and is part of Amerisourcebergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a global pharmaceutical support vehicle through December...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FECRX
    Delivery Order

This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $1,559.25 and a completion date of May 22, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/20/25, 10:04 AM